Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer's disease

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Minter, Myles R ^a,b   Zhang, Can ^c   Leone, Vanessa ^a,b   Ringus, Daina L ^a,b   Zhang, Xiaoqiong ^a   Oyler Castrillo, Paul ^a   Musch, Mark W ^a,b   Liao, Fan ^d   Ward, Joseph F ^c   Holtzman, David M ^d   Chang, Eugene B ^a,b   Tanzi, Rudolph E ^c   Sisodia, Sangram S ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b University of Chicago   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DYSBIOSIS; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; INTESTINE FLORA; MOUSE; PATHOPHYSIOLOGY;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMALS; ANTI-BACTERIAL AGENTS; DISEASE MODELS, ANIMAL; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; IMMUNITY, INNATE; INFLAMMATION; MICE;

EID: 84979276209     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep30028     Document Type: Article

References (54)

1. Arends, Y. M., Duyckaerts, C., Rozemuller, J. M., Eikelenboom, P. & Hauw, J. J. Microglia, amyloid and dementia in alzheimer disease. A correlative study. Neurobiology of aging 21, 39-47 (2000).
2. Beach, T. G., Walker, R. & McGeer, E. G. Patterns of gliosis in Alzheimers disease and aging cerebrum. Glia 2, 420-436, doi: 10.1002/glia.440020605 (1989).
3. Delacourte, A. General and dramatic glial reaction in Alzheimer brains. Neurology 40, 33-37 (1990).
4. Cagnin, A. et al. In-vivo measurement of activated microglia in dementia. Lancet 358, 461-467, doi: 10.1016/S0140-6736(01)05625- 2 (2001).
5. Yasuno, F. et al. Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment-dementia converters measured by positron emission tomography with [(1)(1)C]DAA1106. Psychiatry research 203, 67-74, doi: 10.1016/j. pscychresns.2011.08.013 (2012).
6. Griciuc, A. et al. Alzheimers disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78, 631-643, doi: 10.1016/j. neuron.2013.04.014 (2013).
7. Guerreiro, R. et al. TREM2 variants in Alzheimers disease. The New England journal of medicine 368, 117-127, doi: 10.1056/ NEJMoa1211851 (2013).
8. Jonsson, T. et al. Variant of TREM2 associated with the risk of Alzheimers disease. The New England journal of medicine 368, 107-116, doi: 10.1056/NEJMoa1211103 (2013).
9. Lambert, J. C. et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimers disease. Nature genetics 41, 1094-1099, doi: 10.1038/ng.439 (2009).
10. Naj, A. C. et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimers disease. Nature genetics 43, 436-441, doi: 10.1038/ng.801 (2011).
11. Naj, A. C. et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA neurology 71, 1394-1404, doi: 10.1001/jamaneurol.2014.1491 (2014).
12. Minter, M. R., Taylor, J. M. & Crack, P. J. The contribution of neuroinflammation to amyloid toxicity in Alzheimers disease. Journal of neurochemistry 136, 457-474, doi: 10.1111/jnc.13411 (2016).
13. Chakrabarty, P. et al. IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior. Neuron 85, 519-533, doi: 10.1016/j.neuron.2014.11.020 (2015).
14. Guillot-Sestier, M. V. et al. Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron 85, 534-548, doi: 10.1016/j.neuron.2014.12.068 (2015).
15. He, P. et al. Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimers mice. The Journal of cell biology 178, 829-841, doi: 10.1083/jcb.200705042 (2007).
16. Heneka, M. T. et al. NLRP3 is activated in Alzheimers disease and contributes to pathology in APP/PS1 mice. Nature 493, 674-678, doi: 10.1038/nature11729 (2013).
17. Vom Berg, J. et al. Inhibition of IL-12/IL-23 signaling reduces Alzheimers disease-like pathology and cognitive decline. Nature medicine 18, 1812-1819, doi: 10.1038/nm.2965 (2012).
18. Baruch, K. et al. Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science 346, 89-93, doi: 10.1126/science.1252945 (2014).
19. Taylor, J. M. et al. Type-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimers disease. Neurobiology of aging 35, 1012-1023, doi: 10.1016/j.neurobiolaging.2013.10.089 (2014).
20. Baruch, K. et al. Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimers disease pathology. Nature communications 6, 7967, doi: 10.1038/ncomms8967 (2015).
21. Gyoneva, S. et al. Systemic inflammation regulates microglial responses to tissue damage in vivo. Glia 62, 1345-1360, doi: 10.1002/ glia.22686 (2014).
22. Sherwin, E., Rea, K., Dinan, T. G. & Cryan, J. F. A gut (microbiome) feeling about the brain. Current opinion in gastroenterology 32, 96-102, doi: 10.1097/MOG.0000000000000244 (2016).
23. Kim, H. R. et al. Delivery modes and neonatal EEG: spatial pattern analysis. Early human development 75, 35-53 (2003).
24. Juarez, I., Gratton, A. & Flores, G. Ontogeny of altered dendritic morphology in the rat prefrontal cortex, hippocampus, and nucleus accumbens following Cesarean delivery and birth anoxia. The Journal of comparative neurology 507, 1734-1747, doi: 10.1002/ cne.21651 (2008).
25. Bashir, M. E., Louie, S., Shi, H. N. & Nagler-Anderson, C. Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. Journal of immunology 172, 6978-6987 (2004).
26. Hormann, N. et al. Gut microbial colonization orchestrates TLR2 expression, signaling and epithelial proliferation in the small intestinal mucosa. PloS one 9, e113080, doi: 10.1371/journal.pone.0113080 (2014).
27. Wang, Y. et al. An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling. Nature communications 5, 4432, doi: 10.1038/ncomms5432 (2014).
28. Erny, D. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nature neuroscience 18, 965-977, doi: 10.1038/nn.4030 (2015).
29. Jankowsky, J. L. et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Human molecular genetics 13, 159-170, doi: 10.1093/hmg/ddh019 (2004).
30. Jankowsky, J. L. et al. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomolecular engineering 17, 157-165 (2001).
31. Lathrop, S. K. et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 478, 250-254, doi: 10.1038/nature10434 (2011).
32. Sun, J. et al. Pancreatic beta-Cells Limit Autoimmune Diabetes via an Immunoregulatory Antimicrobial Peptide Expressed under the Influence of the Gut Microbiota. Immunity 43, 304-317, doi: 10.1016/j.immuni.2015.07.013 (2015).
33. Zhang, Z. et al. Peripheral Lymphoid Volume Expansion and Maintenance Are Controlled by Gut Microbiota via RALDH(+) Dendritic Cells. Immunity 44, 330-342, doi: 10.1016/j.immuni.2016.01.004 (2016).
34. Johnson-Wood, K. et al. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 94, 1550-1555 (1997).
35. Garai, K., Verghese, P. B., Baban, B., Holtzman, D. M. & Frieden, C. The binding of apolipoprotein E to oligomers and fibrils of amyloid-beta alters the kinetics of amyloid aggregation. Biochemistry 53, 6323-6331, doi: 10.1021/bi5008172 (2014).
36. Liao, F. et al. Anti-ApoE antibody given after plaque onset decreases Abeta accumulation and improves brain function in a mouse model of Abeta amyloidosis. The Journal of neuroscience: the official journal of the Society for Neuroscience 34, 7281-7292, doi: 10.1523/JNEUROSCI.0646-14.2014 (2014).
37. Liao, F. et al. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models. Acta neuropathologica communications 3, 70, doi: 10.1186/s40478-015- 0250-y (2015).
38. Villeda, S. A. et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477, 90-94, doi: 10.1038/nature10357 (2011).
39. Lalli, M. A. et al. Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimers disease. Molecular psychiatry 20, 1294-1300, doi: 10.1038/mp.2015.131 (2015).
40. Erickson, M. A., Morofuji, Y., Owen, J. B. & Banks, W. A. Rapid transport of CCL11 across the blood-brain barrier: regional variation and importance of blood cells. The Journal of pharmacology and experimental therapeutics 349, 497-507, doi: 10.1124/ jpet.114.213074 (2014).
41. Song, M. et al. TLR4 mutation reduces microglial activation, increases Abeta deposits and exacerbates cognitive deficits in a mouse model of Alzheimers disease. Journal of neuroinflammation 8, 92, doi: 10.1186/1742-2094-8-92 (2011).
42. Stefka, A. T. et al. Commensal bacteria protect against food allergen sensitization. Proceedings of the National Academy of Sciences of the United States of America 111, 13145-13150, doi: 10.1073/pnas.1412008111 (2014).
43. Hagihara, H., Toyama, K., Yamasaki, N. & Miyakawa, T. Dissection of hippocampal dentate gyrus from adult mouse. J Vis Exp, doi: 10.3791/1543 (2009).
44. Wang, Y. et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. The ISME journal 3, 944-954, doi: 10.1038/ismej.2009.37 (2009).
45. Leone, V. et al. Effects of diurnal variation of gut microbes and high-fat feeding on host circadian clock function and metabolism. Cell host & microbe 17, 681-689, doi: 10.1016/j.chom.2015.03.006 (2015).
46. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nature methods 7, 335-336, doi: 10.1038/nmeth.f.303 (2010).
47. McDonald, D. et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. The ISME journal 6, 610-618, doi: 10.1038/ismej.2011.139 (2012).
48. Caporaso, J. G. et al. PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics 26, 266-267, doi: 10.1093/bioinformatics/btp636 (2010).
49. Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Applied and environmental microbiology 73, 5261-5267, doi: 10.1128/AEM.00062-07 (2007).
50. Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree 2-approximately maximum-likelihood trees for large alignments. PloS one 5, e9490, doi: 10.1371/journal.pone.0009490 (2010).
51. Lozupone, C. & Knight, R. UniFrac: a new phylogenetic method for comparing microbial communities. Applied and environmental microbiology 71, 8228-8235, doi: 10.1128/AEM.71.12.8228-8235.2005 (2005).
52. Wagner, S. L. et al. Soluble gamma-secretase modulators selectively inhibit the production of Abeta42 and augment the production of multiple carboxy-truncated Abeta species. Biochemistry, doi: 10.1021/bi401537v (2014).
53. Choi, S. H. et al. A three-dimensional human neural cell culture model of Alzheimers disease. Nature, doi: 10.1038/nature13800 (2014).
54. Zhang, X. et al. Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimers disease. Proceedings of the National Academy of Sciences of the United States of America 112, 9734-9739, doi: 10.1073/ pnas.1505420112 (2015).